ES2172436B1 - Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. - Google Patents

Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.

Info

Publication number
ES2172436B1
ES2172436B1 ES200002615A ES200002615A ES2172436B1 ES 2172436 B1 ES2172436 B1 ES 2172436B1 ES 200002615 A ES200002615 A ES 200002615A ES 200002615 A ES200002615 A ES 200002615A ES 2172436 B1 ES2172436 B1 ES 2172436B1
Authority
ES
Spain
Prior art keywords
sup
derivatives
agents
group
indolilpiperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200002615A
Other languages
English (en)
Spanish (es)
Other versions
ES2172436A1 (es
Inventor
Pou Silvia Fonquerna
Santacana Lluis Pages
Duran Carles Puig
Pueyo Lidia Soca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Almirall Prodesfarma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200002615A priority Critical patent/ES2172436B1/es
Application filed by Almirall Prodesfarma SA filed Critical Almirall Prodesfarma SA
Priority to DK01992709T priority patent/DK1330453T3/da
Priority to US10/415,693 priority patent/US7189741B2/en
Priority to AU2002223655A priority patent/AU2002223655A1/en
Priority to DE60118434T priority patent/DE60118434T2/de
Priority to AT01992709T priority patent/ATE321761T1/de
Priority to SI200130521T priority patent/SI1330453T1/sl
Priority to EP01992709A priority patent/EP1330453B1/en
Priority to PCT/EP2001/012450 priority patent/WO2002036589A1/en
Priority to PT01992709T priority patent/PT1330453E/pt
Priority to JP2002539348A priority patent/JP4184785B2/ja
Priority to CA002427589A priority patent/CA2427589A1/en
Priority to ES01992709T priority patent/ES2259052T3/es
Priority to PE2001001079A priority patent/PE20020543A1/es
Priority to ARP010105068A priority patent/AR031168A1/es
Priority to MYPI20015021A priority patent/MY155914A/en
Priority to UY27001A priority patent/UY27001A1/es
Publication of ES2172436A1 publication Critical patent/ES2172436A1/es
Application granted granted Critical
Publication of ES2172436B1 publication Critical patent/ES2172436B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES200002615A 2000-10-31 2000-10-31 Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. Expired - Fee Related ES2172436B1 (es)

Priority Applications (17)

Application Number Priority Date Filing Date Title
ES200002615A ES2172436B1 (es) 2000-10-31 2000-10-31 Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
ES01992709T ES2259052T3 (es) 2000-10-31 2001-10-26 Derivados de indolipiperidina como agentes antihistaminicos y antialergicos.
AU2002223655A AU2002223655A1 (en) 2000-10-31 2001-10-26 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
DE60118434T DE60118434T2 (de) 2000-10-31 2001-10-26 Indolylpiperidinderivate als antihistaminische und antiallergische mittel
AT01992709T ATE321761T1 (de) 2000-10-31 2001-10-26 Indolylpiperidinderivate als antihistaminische und antiallergische mittel
SI200130521T SI1330453T1 (sl) 2000-10-31 2001-10-26 Derivati indolilpiperidina kot antihistaminicna in antialergijska sredstva
EP01992709A EP1330453B1 (en) 2000-10-31 2001-10-26 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
PCT/EP2001/012450 WO2002036589A1 (en) 2000-10-31 2001-10-26 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
DK01992709T DK1330453T3 (da) 2000-10-31 2001-10-26 Indolylpiperidinderivater som antihistamin- og anti-allergimidler
JP2002539348A JP4184785B2 (ja) 2000-10-31 2001-10-26 抗ヒスタミン薬及び抗アレルギー薬としてのインドリルピペリジン誘導体
CA002427589A CA2427589A1 (en) 2000-10-31 2001-10-26 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
US10/415,693 US7189741B2 (en) 2000-10-31 2001-10-26 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
PT01992709T PT1330453E (pt) 2000-10-31 2001-10-26 Derivados de indolilpiperidina como agentes anti-histaminicos e antialergicos
PE2001001079A PE20020543A1 (es) 2000-10-31 2001-10-30 Derivados de la indolilpiperidina como agentes antihistaminicos y antialergicos
ARP010105068A AR031168A1 (es) 2000-10-31 2001-10-30 Derivados de la indolilpiperidina como agentes antihistaminicos y antialergicos
MYPI20015021A MY155914A (en) 2000-10-31 2001-10-30 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
UY27001A UY27001A1 (es) 2000-10-31 2001-10-31 Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200002615A ES2172436B1 (es) 2000-10-31 2000-10-31 Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.

Publications (2)

Publication Number Publication Date
ES2172436A1 ES2172436A1 (es) 2002-09-16
ES2172436B1 true ES2172436B1 (es) 2004-01-16

Family

ID=8495472

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200002615A Expired - Fee Related ES2172436B1 (es) 2000-10-31 2000-10-31 Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
ES01992709T Expired - Lifetime ES2259052T3 (es) 2000-10-31 2001-10-26 Derivados de indolipiperidina como agentes antihistaminicos y antialergicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES01992709T Expired - Lifetime ES2259052T3 (es) 2000-10-31 2001-10-26 Derivados de indolipiperidina como agentes antihistaminicos y antialergicos.

Country Status (16)

Country Link
US (1) US7189741B2 (cg-RX-API-DMAC10.html)
EP (1) EP1330453B1 (cg-RX-API-DMAC10.html)
JP (1) JP4184785B2 (cg-RX-API-DMAC10.html)
AR (1) AR031168A1 (cg-RX-API-DMAC10.html)
AT (1) ATE321761T1 (cg-RX-API-DMAC10.html)
AU (1) AU2002223655A1 (cg-RX-API-DMAC10.html)
CA (1) CA2427589A1 (cg-RX-API-DMAC10.html)
DE (1) DE60118434T2 (cg-RX-API-DMAC10.html)
DK (1) DK1330453T3 (cg-RX-API-DMAC10.html)
ES (2) ES2172436B1 (cg-RX-API-DMAC10.html)
MY (1) MY155914A (cg-RX-API-DMAC10.html)
PE (1) PE20020543A1 (cg-RX-API-DMAC10.html)
PT (1) PT1330453E (cg-RX-API-DMAC10.html)
SI (1) SI1330453T1 (cg-RX-API-DMAC10.html)
UY (1) UY27001A1 (cg-RX-API-DMAC10.html)
WO (1) WO2002036589A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2201899B1 (es) 2002-04-01 2005-06-01 Almirall Prodesfarma, S.A. Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos.
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
MY135686A (en) * 2002-06-24 2008-06-30 Schering Corp Indole derivatives useful as histamine h3 antagonists
AU2003297597A1 (en) * 2002-11-26 2004-06-18 Isis Pharmaceuticals, Inc. Benzimidazoles and analogs thereof as antibacterials
WO2007050381A2 (en) * 2005-10-24 2007-05-03 Janssen Pharmaceutica, N.V. 3-piperidin-4-yl-indole orl-1 receptor modulators
ATE537166T1 (de) * 2006-10-27 2011-12-15 Boehringer Ingelheim Int Piperidylpropanthiole als ccr3-modulatoren
US8536168B2 (en) * 2007-03-15 2013-09-17 Novartis Ag Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK471479A (da) 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
US4742057A (en) * 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
US4843068A (en) 1985-12-27 1989-06-27 Nihon Nohyaku Co., Ltd. Pyrazole oxime derivatives and compositions
DK733788A (da) 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
DE69330823T2 (de) * 1992-02-13 2002-05-02 Merrell Pharmaceuticals Inc., Cincinnati Thiacyclische piperidinylderivate
JP3338913B2 (ja) * 1993-06-29 2002-10-28 大鵬薬品工業株式会社 テトラゾール誘導体
IT1271417B (it) 1993-10-15 1997-05-28 Erregierre Ind Chim Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
DE19500689A1 (de) 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
DE19707628A1 (de) 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
AR013669A1 (es) 1997-10-07 2001-01-10 Smithkline Beecham Corp Compuestos y metodos
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AR028685A1 (es) 2000-06-14 2003-05-21 Lundbeck & Co As H Derivados de indol

Also Published As

Publication number Publication date
UY27001A1 (es) 2001-12-28
ES2172436A1 (es) 2002-09-16
AR031168A1 (es) 2003-09-10
CA2427589A1 (en) 2002-05-10
DE60118434T2 (de) 2006-12-14
US20040116471A1 (en) 2004-06-17
ATE321761T1 (de) 2006-04-15
WO2002036589A1 (en) 2002-05-10
US7189741B2 (en) 2007-03-13
AU2002223655A1 (en) 2002-05-15
PE20020543A1 (es) 2002-07-17
SI1330453T1 (sl) 2006-08-31
EP1330453B1 (en) 2006-03-29
EP1330453A1 (en) 2003-07-30
PT1330453E (pt) 2006-07-31
MY155914A (en) 2015-12-15
DK1330453T3 (da) 2006-08-07
DE60118434D1 (de) 2006-05-18
ES2259052T3 (es) 2006-09-16
JP2004513127A (ja) 2004-04-30
JP4184785B2 (ja) 2008-11-19

Similar Documents

Publication Publication Date Title
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
PE20020476A1 (es) Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos
UY27870A1 (es) Nuevos derivados de quinuclidina-amida
AR029821A1 (es) Decahidro-isoquinolinas, un proceso para su preparacion, composiciones farmaceuticas que las comprenden y el uso de las mismas para la fabricacion de un medicamento
PA8575401A1 (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso
ECSP066312A (es) Derivados piridilo y su uso como agentes terapéuticos
AR032436A1 (es) Oxazolidinonas substituidas, procedimiento para su preparacion, medicamentos, el uso de las mismas para la fabricacion de medicamentos, y el metodo para impedir la coagulacion sanguinea in vitro
ECSP066315A (es) Derivados de la piridazina y su uso como agentes terapéuticos
UY27740A1 (es) Nuevos compuestos
PA8569201A1 (es) "derivados de bencimidazol n3 alquilado como inhibidores de mek" "n3 alkylated benzimimidazole derivatives as mek inhibitors"
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
GT200100174A (es) Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados.
AR031597A1 (es) Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3
AR035153A1 (es) Derivados de carboxamidas y cetonas de dihidrobenzodioxina
PA8576101A1 (es) Difenilazetidinonas sustituidas en grupo acido, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
ECSP045278A (es) Compuestos de oxo-azabicíclicos
PE106099A1 (es) Uso de derivados hidroxicumaranonas sustituidos como agentes antitumorales y antimetastasicos
AR029373A1 (es) Metodo para el tratamiento de migranas, utilizando compuestos antagonistas selectivos de los receptores iglur5, uso de dichos compuestos antagonistas selectivos en la manufactura de medicamentos para el tratamiento de migranas y dichos compuestos antagonistas
AR029795A1 (es) Derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico sustituidos, procedimientos para su preparacion, su uso para la preparacion de medicamentos y medicamentos que contienen estos compuestos
AR027335A1 (es) Compuestos de piperidina-4-sulfonamida, proceso de preparacion de los mismos, y composiciones farmaceuticas que los contienen
AR046874A1 (es) Nuevos metodos
AR037521A1 (es) Derivados de piperazina que tienen actividad antagonista del sst1, un proceso para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de la depresion, ansiedad y padecimientos bipolares y una combinacion
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
UY28979A1 (es) Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20020916

Kind code of ref document: A1

Effective date: 20020916

FG2A Definitive protection

Ref document number: 2172436B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100315